Continued high risk behaviors in HIV infected drug abusers

Journal of Addictive Diseases

Volumn 21, Issue 4, 2002, Pages 67-80

  Miguez Burbano, Maria Jose ^a   Pineda Medina, Luisamaria ^a   Lecusay, Robert ^a   Bryan Page, J ^a   Castillo, Gloria ^a   Burbano, Ximena ^a   Rodriguez, Allan ^a   Rodriguez, Noaris ^a   Shor Posner, Gail ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Drug abusers; HAART; HIV; Long term survivors; Relapse

Indexed keywords

AMPHETAMINE DERIVATIVE; ANTIRETROVIRUS AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; COCAINE DERIVATIVE; DEXTROPROPOXYPHENE; METHADONE; OPIATE DERIVATIVE; PHENCYCLIDINE; PLACEBO; SELENIUM; TETRAHYDROCANNABINOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONDOM; DEMOGRAPHY; DRUG ABUSE; FEMALE; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE; NEEDLE; PREVALENCE; RISK ASSESSMENT; SEXUAL BEHAVIOR; VIRAL CONTAMINATION; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DOUBLE-BLIND METHOD; FEMALE; FLORIDA; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 0036403010     PISSN: 10550887     EISSN: None     Source Type: Journal    
DOI: 10.1300/J069v21n04_07     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. HIV Counseling, Testing and Referral: Standards and Guidelines. Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, CDC, May 1994.
2. Denning PH, Nakashima AK, Wortley P, et al. High-risk sexual behaviors among HIV-infected adolescents and young adults. 1999 National HIV Prevention Conference, Abstract 113, Atlanta, Georgia, August 29-September 1, 1999.
3. Weinhardt LS, Carey MP, Johnson BT, Bickham NL. Effects of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published research, 1985-1997. Am J Public Health. 1999;89:1397-1405.
4. Wolitski RJ, Mac Gowan RJ, Higgins DL, Jorgensen CM. The effects of HIV counseling and testing on risk-related practices and help-seeking behavior. AIDS Educ Prev Suppl. 1997;B:52-67.
5. Ekstrand ML, Coates TJ, Stall RD. Maintenance of AIDS behavior change and predictors of risky sex among San Francisco gay men. In: JA Kelly, Factors influencing AIDS risk behavior reduction: Implications for primary prevention. Symposium Presented at the 23rd Annual Convention of the Association for the Advancement of Behavior Therapy, Washington, DC, 1989.
6. Ekstrand ML, Coates TJ. Maintenance of safer sexual behaviors and predictors of risky sex: The San Francisco men's health study. American Journal of Public Health. 1990;80:973-977.
7. Kelly JA, Hoffmann RG, Rompa D, Gray M. Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex. AIDS. 1998;12:F91-F95.
8. Miller M, Meyer L, Boufassa F, et al. Sexual behavior changes and protease inhibitor therapy. AIDS. 2000;14:F33-39.
9. Roffman AR, Stephens RS, Curtin L, et al. Relapse prevention as an interventive model for HIV risk reduction in gay and bisexual men. AIDS Education and Prevention. 1998;10(1):1-18.
10. Sherman DW, Kirton CA. The experience of relapse to unsafe sexual behavior among HIV-positive, heterosexual, minority men. Applied Nursing Research. 1999; 12(2):91-100.
11. Choi K, Coates C. Prevention of HIV infection. AIDS. 1994;1371-1389.
12. Fennema JS, van Ameijden EJ, Coutinho RA, Van den Hoek A. Clinical sexually transmitted diseases among HIV-infected and noninfected drug-using prostitutes. Associated factors and interpretation of trends, 1986 to 1994. Sexually Transmitted Diseases. 1997;24(6):363-371.
13. Haverkos H, Quinn T. The third wave: HIV infection among heterosexuals in the United States and Europe. International Journal of STD and AIDS. 1995;6:227-232.
14. Balaguera HU, Hanna GJ, Freedberg KA, et al. Prevalence of HIV genotype resistance in antiretroviral-naïve patients entering care in Boston. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 1247, Toronto, Ontario, Canada, September 17-20, 2000.
15. Briones C, Perez-Olmeda M, Rodríguez C, et al. Primary resistance to antiretroviral drugs in recent seroconverters in Madrid, Spain. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 1245, Toronto, Ontario, Canada, September 17-20, 2000.
16. McClemon DR, Pierce A, Thompson M, et al. Low prevalence of key resistance mutations in geographically diverse, therapy naïve, HIV-1 infected subjects in North America. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 1248, Toronto, Ontario, Canada, September 17-20, 2000.
17. Miguez-Burbano MJ, Angarita I, Shultz JM, et al. HIV-related high risk sexual behaviors and practices among women in Bogota, Colombia. Women & Health. 2000; 30(4):109-119.
18. Cazorla C, Bourlet T, Berthelot P, et al. Compartmentalization of HIV-1 in blood and mucosa according to antiretroviral therapy: Viral loads are correlated in blood and semen, but not in blood and saliva. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 559, Toronto, Ontario, Canada, September 17-20, 2000.
19. Cohen MS. Limits on oral transmission of HIV-1. Lancet. 2000;356:272.
20. Maggiolo F. Once a day therapy for HIV infection. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 1520, Toronto, Ontario, Canada, September 17-20, 2000.
21. Skowron G, Kuritzkes D, Thompson M, et al. ICC-604: A pilot study to evaluate the safety, adherence, antiviral activity and pharmacokinetics (PK) of a novel once daily regimen of adefovir dipivoxil (ADV), lamivudine (3TC), didanosine (ddI) and efavirenz (EFV) in HIV-1 infected patients. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 537, Toronto, Ontario, Canada, September 17-20, 2000.
22. Campbell AJ, Robertson MC, Gardner MM, et al. Falls prevention over 2 years: A randomized controlled trial in women 80 years and older. Age Ageing. 1999; 28(6):513-518.
23. Johansson E, Long NH, Diwan VK, Winkvist A. Attitudes to compliance with tuberculosis treatment among women and men in Vietnam. Int J Turbec Lung Disease. 1999;3(10):862-868.
24. Centers for Disease Control and Prevention. Update: Acquired immunodeficiency syndrome-United States. MMWR. 1996;44:64-67.